LSTA · NASDAQ
Lisata Therapeutics (LSTA) Stock Price & Fundamentals
Lisata Therapeutics (LSTA) closed at $1,228.31 on Oct 9, 2026, up 0.86% from the previous close of $1,217.81.
Share price, past year
1Y +12.17%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,228.31 |
| Sep 30, 2026 | $1,186.93 |
| Aug 31, 2026 | $1,174.20 |
| Jul 31, 2026 | $1,172.45 |
| Jun 30, 2026 | $1,188.20 |
| May 29, 2026 | $1,116.87 |
| Apr 30, 2026 | $1,168.14 |
| Mar 31, 2026 | $1,180.79 |
| Feb 27, 2026 | $1,190.39 |
| Jan 30, 2026 | $1,168.78 |
| Dec 31, 2025 | $1,152.58 |
| Nov 28, 2025 | $1,109.93 |
| Oct 31, 2025 | $1,131.30 |
Key statistics
- Market cap
- $11.20B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.64
- Revenue (TTM)
- $100.00K
- Net income (TTM)
- −$14.62M
- Shares outstanding
- 9.1M
- Dividend yield
- —
- 52-week range
- $1,034.03 – $1,252.69
Lisata Therapeutics's market cap is $11.20B, based on a share price of $1,228.31 and 9.1M shares outstanding as of Jun 30, 2026.
Financials
Lisata Therapeutics reported revenue of $170.00K for fiscal 2024.
Lisata Therapeutics reported a net loss of $16.59M in fiscal 2024.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2025 | $170.00K | −83.0% | −$16.59M | −9,756.5% | −$1.91 | −$15.98M |
| FY2023ended Dec 31, 2024 | $1.00M | — | −$19.99M | −1,998.5% | −$2.40 | −$19.36M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$19.99M | — | −$2.40 | −$19.36M |
| FY2022ended Dec 31, 2022 | $0.00 | −100.0% | −$54.23M | — | −$10.47 | −$21.46M |
| FY2016ended Dec 31, 2016 | $35.28M | +56.9% | −$32.66M | −92.6% | −$4.99 | −$24.77M |
| FY2015ended Dec 31, 2015 | $22.49M | +25.4% | — | — | — | — |
| FY2014ended Dec 31, 2014 | $17.94M | +22.3% | — | — | — | — |
| FY2013ended Dec 31, 2013 | $14.67M | +2.4% | — | — | — | — |
| FY2012ended Dec 31, 2012 | $14.33M | +42.6% | — | — | — | — |
| FY2011ended Dec 31, 2011 | $10.05M | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2025ended Jun 30, 2026 | $0.00 | −$2.93M | −$0.32 |
| Q1 FY2025ended Mar 31, 2026 | $0.00 | −$4.49M | −$0.50 |
| Q4 FY2024ended Dec 31, 2025 | $100.00K | −$2.95M | −$0.33 |
| Q3 FY2024ended Sep 30, 2025 | $0.00 | −$4.25M | −$0.49 |
| Q2 FY2024ended Jun 30, 2025 | $70.00K | −$4.66M | −$0.54 |
| Q1 FY2024ended Mar 31, 2025 | $0.00 | −$4.72M | −$0.55 |
| Q4 FY2023ended Dec 31, 2024 | $1.00M | −$4.61M | −$0.55 |
| Q3 FY2023ended Sep 30, 2024 | $0.00 | −$4.93M | −$0.59 |
Company profile
- Name
- Lisata Therapeutics, Inc.
- Ticker
- LSTA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 110 Allen Road, Second Floor, Basking Ridge, NJ 07920
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000320017
Recent SEC filings
- Sep 17, 2026
- Aug 6, 2026
- Aug 4, 2026
- Jul 24, 2026
- Jul 17, 2026
- Jun 9, 2026
- Jun 1, 2026
- May 29, 2026
Frequently asked questions
What is Lisata Therapeutics's stock price?
Lisata Therapeutics (LSTA) closed at $1,228.31 on Oct 9, 2026, up 0.86% from the previous close of $1,217.81.
What is Lisata Therapeutics's market cap?
Lisata Therapeutics's market cap is $11.20B, based on a share price of $1,228.31 and 9.1M shares outstanding as of Jun 30, 2026.
How much revenue does Lisata Therapeutics make?
Lisata Therapeutics reported revenue of $170.00K for fiscal 2024.
Does Lisata Therapeutics pay a dividend?
Lisata Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Lisata Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures